Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families

A C Houweling, L M Gijezen, M A Jonker, M B A van Doorn, R A Oldenburg, K Y van Spaendonck-Zwarts, E M Leter, T A van Os, N C T van Grieken, E H Jaspars, M M de Jong, E M H F Bongers, P C Johannesma, P E Postmus, R J A van Moorselaar, J-Htm van Waesberghe, T M Starink, M A M van Steensel, J J P Gille, F H Menko, A C Houweling, L M Gijezen, M A Jonker, M B A van Doorn, R A Oldenburg, K Y van Spaendonck-Zwarts, E M Leter, T A van Os, N C T van Grieken, E H Jaspars, M M de Jong, E M H F Bongers, P C Johannesma, P E Postmus, R J A van Moorselaar, J-Htm van Waesberghe, T M Starink, M A M van Steensel, J J P Gille, F H Menko

Abstract

Background: Birt-Hogg-Dubé (BHD) syndrome is an autosomal dominant condition caused by germline FLCN mutations, and characterised by fibrofolliculomas, pneumothorax and renal cancer. The renal cancer risk, cancer phenotype and pneumothorax risk of BHD have not yet been fully clarified. The main focus of this study was to assess the risk of renal cancer, the histological subtypes of renal tumours and the pneumothorax risk in BHD.

Methods: In this study we present the clinical data of 115 FLCN mutation carriers from 35 BHD families.

Results: Among 14 FLCN mutation carriers who developed renal cancer 7 were <50 years at onset and/or had multifocal/bilateral tumours. Five symptomatic patients developed metastatic disease. Two early-stage cases were diagnosed by surveillance. The majority of tumours showed characteristics of both eosinophilic variants of clear cell and chromophobe carcinoma. The estimated penetrance for renal cancer and pneumothorax was 16% (95% minimal confidence interval: 6-26%) and 29% (95% minimal confidence interval: 9-49%) at 70 years of age, respectively. The most frequent diagnosis in families without identified FLCN mutations was familial multiple discoid fibromas.

Conclusion: We confirmed a high yield of FLCN mutations in clinically defined BHD families, we found a substantially increased lifetime risk of renal cancer of 16% for FLCN mutation carriers. The tumours were metastatic in 5 out of 14 patients and tumour histology was not specific for BHD. We found a pneumothorax risk of 29%. We discuss the implications of our findings for diagnosis and management of BHD.

Figures

Figure 1
Figure 1
(A) Estimate of the age-related penetrance function for renal cancer based on available data on both mutation carriers and their untested relatives till the age of 70: 16% (continuous line n=86 mutation carriers and 84 untested relatives), together with the Kaplan–Meier estimator based on the known mutation carriers only at age 70: 20% (n=86, red dashed line). (B) Estimate of the age-related penetrance function for renal cancer based on available data on both mutation carriers and their untested relatives together with a minimum 95% confidence interval. Estimated penetrance at age 70: 16%, 95% minimal confidence interval: (6-26%). (C) Estimation of the penetrance function of age at the first pneumothorax and a minimum 95% confidence interval based on available data on both mutation carriers and their untested relatives (n=85 mutation carriers and 84 untested relatives). Estimated penetrance at age 70: 29%, 95% minimal confidence interval: (9–49%).
Figure 2
Figure 2
Overview of the FLCN mutations identified in this study. Del: deletion, F: frameshift, M: missense, N: nonsense, SS: splice site. Exons are depicted as rectangles. The family numbers are shown after the mutations.
Figure 3
Figure 3
Illustration of the histological pictures of renal cell carcinomas in our series. (A) The most common pattern found, classified as clear cell/chromophobe. The tumour cells show eosinophilic cytoplasm, moderate nuclear pleiomorphism, vague perinuclear halos, no explicit cell borders and no vascular prominence. (B) Classical picture of clear cell carcinoma, as can be seen in many of the tumours in our series, but mostly only in part of the tumour cells. (C) A clear cell/chromophobe renal cell carcinoma with partially clear cytoplasm, more prominent cell borders, no thick-walled vessels. (D) Renal cell carcinoma with sarcomatoid changes (in the right part of the picture).

References

    1. Benhammou JN, Vocke CD, Santani A, Schmidt LS, Baba M, Seyama K, Wu X, Korolevich S, Nathanson KL, Stolle CA, Linehan WM (2011) Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome. Genes Chromosomes Cancer 50(6): 466–477
    1. Birt AR, Hogg GR, Dubé WJ (1977) Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 113(12): 1674–1677
    1. Gatalica Z, Lilleberg SL, Vranic S, Eyzaguirre E, Orihuela E, Velagaleti G (2009) Novel intronic germline FLCN gene mutation in a patient with multiple ipsilateral renal neoplasms. Hum Pathol 40(12): 1813–1819
    1. Graham RB, Nolasco M, Peterlin B, Garcia CK (2005) Nonsense mutations in folliculin presenting as isolated familial spontaneous pneumothorax in adults. Am J Respir Crit Care Med 172(1): 39–44
    1. Hasumi Y, Baba M, Ajima R, Hasumi H, Valera VA, Klein ME, Haines DC, Merino MJ, Hong SB, Yamaguchi TP, Schmidt LS, Linehan WM (2009) Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc Natl Acad Sci 106(44): 18722–18727
    1. Hornstein OP, Knickenberg M (1975) Perifollicular fibromatosis cutis with polyps of the colon – a cutaneo-intestinal syndrome sui generis. Arch Dermatol Res 253(2): 161–175
    1. Johannesma PC, Lammers JW, van Moorselaar RJ, Starink TM, Postmus PE, Menko FH (2009) Spontaneous pneumothorax as the first manifestation of a hereditary condition with an increased renal cancer risk. Ned Tijdschr Geneeskd 153: A581 (in Dutch)
    1. Khoo SK, Giraud S, Kahnoski K, Chen J, Motorna O, Nickolov R, Binet O, Lambert D, Friedel J, Lévy R, Ferlicot S, Wolkenstein P, Hammel P, Bergerheim U, Hedblad MA, Bradley M, Teh BT, Nordenskjöld M, Richard S (2002) Clinical and genetic studies of Birt-Hogg-Dubé syndrome. J Med Genet 39(12): 906–912
    1. Kummerlin I, ten Kate F, Smedts F, Horn T, Algaba F, Trias I, de la Rosette J, Laguna MP (2009) Diagnostic problems in the subtyping of renal tumors encountered by five pathologists. Pathol Res Pract 205(1): 27–34
    1. Kunogi M, Kurihara M, Ikegami TS, Kobayashi T, Shindo N, Kumasaka T, Gunji Y, Kikkawa M, Iwakami S, Hino O, Takahashi K, Seyama K (2010) Clinical and genetic spectrum of Birt-Hogg-Dubé syndrome patients in whom pneumothorax and/or multiple lung cysts are the presenting feature. J Med Genet 47(4): 281–287
    1. Leter EM, Koopmans AK, Gille JJP, Van Os TAM, Vittoz GG, David EFL, Jaspars EH, Postmus PE, van Moorselaar RJA, Craanen ME, Starink TM, Menko FH (2008) Birt-Hogg-Dubé syndrome: clinical and genetic studies of 20 families. J Invest Dermatol 128(1): 45–49
    1. Lopez-Beltran A, Carrasco JC, Cheng L, Scarpelli M, Kirkali Z, Montironi R (2009) 2009 update on the classification of renal epithelial tumors in adults. Int J Urol 16(5): 432–443
    1. Menko FH, van Steensel MAM, Giraud S, Friis-Hansen L, Richard S, Ungari S, Nordenskjöld M, Hansen TV, Solly J, Maher ER (2009) Birt-Hogg-Dubé syndrome: diagnosis and management. Lancet Oncol 10(12): 1199–1206
    1. Nahorski M, Lim DHK, Martin L, Gille JP, Mckay K, Rehal PK, Ploeger HM, van Steensel M, Tomlinson IP, Latif F, Menko FH, Maher ER (2010) Investigation of the Birt-Hogg-Dubé tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer. J Med Genet 47(6): 385–390
    1. Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML, Duray P, Merino M, Choyke P, Pavlovich CP, Sharma N, Walther M, Munroe D, Hill R, Maher E, Greenberg C, Lerman MI, Linehan WM, Zbar B, Schmidt LS (2002) Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell 2(2): 157–164
    1. Painter JN, Tapanainen H, Somer M, Tukiainen P, Aittomäki K (2005) A 4-bp deletion in the Birt-Hogg-Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothorax. Am J Hum Genet 76(3): 522–527
    1. Pavlovich CP, Grubb III RL, Hurley K, Glenn GM, Toro J, Schmidt LS, Torres-Cabala C, Merino MJ, Zbar B, Choyke P, Walther MM, Linehan WM (2005) Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome. J Urol 173(5): 1482–1486
    1. Pavlovich CP, Walther MA, Eyler RA, Hewitt SM, Zbar B, Linehan WM, Merino MJ (2002) Renal tumors in the Birt-Hogg-Dubé syndrome. Am J Surg Pathol 26(12): 1542–1552
    1. Roth JS, Rabinowitz AD, Benson M, Grossman ME (1993) Bilateral renal cell carcinoma in the Birt-Hogg-Dubé syndrome. J Am Acad Dermatol 29(6): 1055–1056
    1. Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, Morrison P, Maher ER, Walther MM, Zbar B, Linehan WM (2005) Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome. Am J Hum Genet 76(6): 1023–1033
    1. Starink TM, Houweling AC, van Doorn MBA, Leter EM, Jaspars EH, van Moorselaar RJA, Postmus PE, Johannesma PC, van Waesberghe JH, Ploeger MH, Kramer MT, Gille JJP, Waisfisz Q, Menko FH (2011) Familial multiple discoid fibromas: a look-alike of Birt-Hogg-Dubé syndrome not linked to the FLCN locus. J Am Acad Dermatol; doi:10.1016/j.jaad.2010.11.039 (in press)
    1. Starink TM, Kisch LS, Meijer CJLM (1985) Familial multiple trichodiscomas – a clinicopathologic study. Arch Dermatol 121(7): 888–891
    1. Toro JR, Glenn G, Duray P, Darling T, Weirich G, Zbar B, Linehan M, Turner ML (1999) Birt-Hogg-Dubé syndrome – a novel marker of kidney neoplasia. Arch Dermatol 135(10): 1195–1202
    1. Toro JR, Pautler SE, Stewart L, Glenn GM, Weinreich M, Toure O, Wei MH, Schmidt LS, Davis L, Zbar B, Choyke P, Steinberg SM, Nguyen DM, Linehan WM (2007) Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dubé syndrome. Am J Respir Crit Care Med 175(10): 1044–1053
    1. Toro JR, Wei MH, Glenn GM, Weinreich M, Toure O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, Steinberg SM, Schmidt LS, Linehan WM (2008) BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet 45(6): 321–331
    1. Woodward ER, Ricketts C, Killick P, Gad S, Morris MR, Kavalier F, Hodgson SV, Giraud S, Bressac-de Paillerets B, Chapman C, Escudier B, Latif F, Richard S, Maher ER (2008) Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN. Clin Cancer Res 14(18): 5925–5930
    1. Zbar B, Alvord WG, Glenn G, Turner M, Pavlovich CP, Schmidt L, Walther M, Choyke P, Weirich G, Hewitt SM, Duray P, Gabril F, Greenberg C, Merino MJ, Toro J, Linehan WM (2002) Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome. Cancer Epidemiol Biomarkers Prev 11(4): 393–400

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren